{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:19:37Z","timestamp":1791299977208,"version":"4.1.0"},"reference-count":31,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2005,10,27]],"date-time":"2005-10-27T00:00:00Z","timestamp":1130371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis &amp; Rheumatism"],"published-print":{"date-parts":[[2005,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>Childhood dermatomyositis (DM) is often a chronic disease, lasting many years. It has traditionally been treated with long\u2010term corticosteroid therapy; side effects are often seen. For more than a decade, methotrexate (MTX) has been safely used for the treatment of juvenile arthritis. Here, we report use of MTX as first\u2010line therapy for DM, along with aggressively tapered corticosteroids, in an attempt to reduce treatment\u2010related side effects.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We studied an inception cohort of 31 children with DM who were rigorously followed up in our myositis clinic, and compared them with a control group of 22 patients with incident cases of juvenile DM who received treatment just before we instituted a policy of first\u2010line therapy with MTX. The mean starting dosage of MTX in the study group was 15 mg\/m<jats:sup>2<\/jats:sup>\/week.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Both groups had similar improvement in strength and physical function; however, the median time during which patients in the study group received corticosteroids was 10 months, compared with 27 months for controls (<jats:italic>P<\/jats:italic> &lt; 0.0001). As a result, the cumulative prednisone dose in the study group was approximately half that in the control group (7,574 mg versus 15,152 mg; <jats:italic>P<\/jats:italic> = 0.0006). The study group had greater height velocity during the first year of treatment and a smaller increase in the body mass index over the first 2 years. In the control group, the relative risk of cataracts developing was 1.95 (95% confidence interval 1.05\u20134.17). Side effects of MTX were rarely observed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Use of MTX in conjunction with an aggressively tapered course of prednisone may be as effective as traditional long\u2010term corticosteroid therapy for children with DM, while decreasing the cumulative dose of corticosteroids.<\/jats:p><\/jats:sec>","DOI":"10.1002\/art.21378","type":"journal-article","created":{"date-parts":[[2005,10,28]],"date-time":"2005-10-28T00:49:00Z","timestamp":1130460540000},"page":"3570-3578","source":"Crossref","is-referenced-by-count":147,"title":["The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids"],"prefix":"10.1002","volume":"52","author":[{"given":"A. V.","family":"Ramanan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Campbell\u2010Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. N.","family":"Tyrrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Spiegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. M.","family":"Laxer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. D.","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. M.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,10,27]]},"reference":[{"key":"e_1_2_5_2_2","first-page":"441","article-title":"Incidence of chronic juvenile rheumatic diseases in Finland during 1980\u20101990","volume":"14","author":"Kaipiainen\u2010Seppanen O","year":"1996","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_5_3_2","first-page":"1329","article-title":"Incidence of polymyositis\u2010dermatomyositis: a 20\u2010year study of hospital diagnosed cases in Allegheny County, PA 1963\u20101982","volume":"17","author":"Oddis CV","year":"1990","journal-title":"J Rheumatol"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/34.8.732"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(84)80012-8"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200003)43:3<541::AID-ANR9>3.0.CO;2-T"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(83)80706-9"},{"key":"e_1_2_5_8_2","first-page":"1140","article-title":"Dermatopolymyositis and other connective tissue diseases: a review of 105 cases","volume":"12","author":"Tymms KE","year":"1985","journal-title":"J Rheumatol"},{"key":"e_1_2_5_9_2","first-page":"283","article-title":"Polymyositis\/dermatomyositis: clinical features and outcome in 22 patients","volume":"12","author":"Baron M","year":"1985","journal-title":"J Rheumatol"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7258(02)00297-8"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199803)41:3<381::AID-ART2>3.0.CO;2-3"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199204163261602"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.2165\/00128072-200204050-00004"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780351006"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s100670050032"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199803)41:3<392::AID-ART3>3.0.CO;2-X"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(93)90148-I"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.122196"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-857X(02)00024-8"},{"key":"e_1_2_5_20_2","unstructured":"WulffraatN ElstE PilkingtonC for thePRES Working Group of JDM.Initial treatment of JDM: a survey among PRINTO members. Proceedings of the 10th European Pediatric Rheumatology Congress Annual Scientific Meeting of PRES;2003Oct 2\u20135; Stresa Italy."},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197502202920807"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197502132920706"},{"key":"e_1_2_5_23_2","first-page":"326","article-title":"Measuring disability in juvenile dermatomyositis: validity of the childhood health assessment questionnaire","volume":"22","author":"Feldman BM","year":"1995","journal-title":"J Rheumatol"},{"key":"e_1_2_5_24_2","first-page":"1106","article-title":"Validation of the Childhood Health Assessment Questionnaire in the juvenile idiopathic myopathies","volume":"28","author":"Huber AM","year":"2001","journal-title":"J Rheumatol"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780350502"},{"key":"e_1_2_5_26_2","volume-title":"Aids to the examination of the peripheral nervous system","author":"Medical Research Council","year":"1986"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(81)90073-4"},{"key":"e_1_2_5_28_2","first-page":"1044","article-title":"Patient, observer and instrument variation in the measurement of strength of shoulder abductor muscles in patients with rheumatoid arthritis using a modified sphygmomanometer","volume":"13","author":"Helewa A","year":"1986","journal-title":"J Rheumatol"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-857X(05)70362-8"},{"issue":"2","key":"e_1_2_5_30_2","first-page":"332","article-title":"Persistence of activity in dermatomyositis of childhood","volume":"20","author":"Miller JJ","year":"1977","journal-title":"Arthritis Rheum"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780300312"},{"key":"e_1_2_5_32_2","first-page":"2498","article-title":"Intravenous immunoglobulin therapy for juvenile dermatomyositis: efficacy and safety","volume":"27","author":"Al\u2010Mayouf SM","year":"2000","journal-title":"J Rheumatol"}],"container-title":["Arthritis &amp; Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.21378","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.21378","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T04:40:08Z","timestamp":1696999208000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.21378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,27]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["10.1002\/art.21378"],"URL":"https:\/\/doi.org\/10.1002\/art.21378","archive":["Portico"],"relation":{},"ISSN":["0004-3591","1529-0131"],"issn-type":[{"value":"0004-3591","type":"print"},{"value":"1529-0131","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,27]]}}}